Search results
24 maj 2023 · Fetal echocardiography is indicated in the setting of abnormal results on screening ultrasound of the heart regardless of additional risk factors; below are recommended indications for fetal echocardiography on the basis of a priori risk from previously published guidelines and the current document.
- Fetal Echocardiography From 10 to 15 Weeks of Gestation—Reliability ...
There is increasing demand for accurate early fetal cardiac...
- Fetal Echocardiography From 10 to 15 Weeks of Gestation—Reliability ...
The diagnosis of cardiac disease in the fetus is mostly made with ultrasound; however, new technologies, including 3- and 4-dimensional echocardiography, magnetic resonance imaging, and fetal electrocardiography and magnetocardiography, are available.
Indications for performance of fetal echocardiography (Table 1), the gold standard test to diagnose congenital heart disease (CHD) in the fetus, have evolved over the years. The discussion in this section hinges on the quality and sensitivity of prenatal ultrasound screening for cardiac abnormalities, the basic or detailed obstetric anatomic ul-
2 cze 2023 · Effective fetal cardiac screening should maximize detection of structural anomalies and (according to available expertise and resources) abnormalities of function and rhythm, as part of routine prenatal care.
18 mar 2024 · In 2013 we implemented a fetal echocardiography‐based algorithm targeting fetuses considered high risk for acute cardiorespiratory instability at ≤2 hours of birth for delivery in our pediatric cardiac operating room of our children's hospital, and, herein, examine our experience.
The purpose of this document is to provide updated recommendations for the performance and interpretation of fetal echocardiography in the detection, classification, risk assessment, and perinatal care planning of the pregnancy in which the fetus has cardiovascular disease.
30 sie 2024 · There is increasing demand for accurate early fetal cardiac disease (FCD). We assessed the accuracy of early fetal echo (EFE) conducted in our high-volume fetal cardiac program and reviewed the spectrum of FCD, associated genetic anomalies, and outcomes encountered.
